Laboratory Filtration Market

Merck KGaA (Germany) and Danaher Corporation (US) are the Leading Players in Laboratory Filtration Market

The laboratory filtration market is projected to reach USD 6.55 billion by 2031 from an estimated USD 4.49 billion in 2026, at a CAGR of 7.9%. Market growth is driven by increasing pharmaceutical and biotechnology R&D spending, growing adoption of membrane filtration technologies, rising demand for single-use filtration products, and increasing emphasis on product quality and regulatory compliance. Expanding research and development activities involving monoclonal antibodies, vaccines, cell and gene therapies, and mRNA-based therapeutics are driving demand for reliable sample preparation, sterile filtration, and purification technologies. The growing adoption of microfiltration, ultrafiltration, and nanofiltration further supports market expansion. Demand for membrane filters, syringe filters, syringeless filters, filtration assemblies, and related consumables is also increasing across pharmaceutical and biotechnology companies, academic and research institutes, and clinical laboratories

The global laboratory filtration market is moderately consolidated, with Merck KGaA (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), and Sartorius AG (Germany) holding the major share of the market in 2025. Competition centers on membrane performance, filtration efficiency, product quality, chemical compatibility, application coverage, and the ability to support diverse laboratory workflows. Product innovation, portfolio expansion, strategic acquisitions, collaborations, and manufacturing capacity expansions are prominent strategies market participants use. Merck KGaA and Sartorius have strengthened their filtration portfolios and manufacturing capabilities, while Danaher and Thermo Fisher Scientific have expanded their filtration technologies and downstream purification capabilities through product developments and strategic investments.

To know about the assumptions considered for the study download the pdf brochure

In September 2026, Sterlitech Corporation launched MembraMax, a range of benchtop membrane filtration systems designed for laboratory research and membrane process development. The systems support microfiltration, ultrafiltration, nanofiltration, reverse osmosis, and other membrane separation processes.

In September 2025, Thermo Fisher Scientific completed the acquisition of Solventum's Purification & Filtration business for approximately USD 4.0 billion, strengthening its filtration and separation portfolio with advanced membrane technologies supporting biopharmaceutical research, purification, and upstream and downstream processing applications.

Merck KGaA (Germany)

Merck KGaA is a leading player in the laboratory filtration market through its Life Science business. The company's portfolio includes Millex syringe filters, Amicon ultrafiltration devices, Stericup vacuum filtration systems, Steritop bottle-top filters, and Millipore membrane filters used across pharmaceutical, biotechnology, and analytical laboratories. Its core competencies lie in membrane technologies, sterile filtration, sample preparation, and laboratory-scale protein concentration and purification. The company's filtration products support research, quality control, and biopharmaceutical development workflows. In September 2025, Merck opened a USD 175.8 million (EUR 150 million) filtration manufacturing facility in Cork, Ireland, expanding its production capabilities for aseptic processing, tangential flow filtration, and virus filtration applications.

Danaher Corporation (US)

Danaher Corporation holds a strong position in the laboratory filtration market through Cytiva and its integrated Pall Life Sciences portfolio. The company offers Whatman filter papers, membrane filters, syringe filters, capsule filters, sterilizing-grade filters, and tangential flow filtration systems for laboratory sample preparation, clarification, sterile filtration, and biomolecule purification. Its core competencies include high-performance membrane technologies, filtration efficiency, single-use systems, and integrated downstream purification solutions. In May 2023, Pall Life Sciences was integrated with Cytiva, bringing complementary filtration, separation, and bioprocessing capabilities under one business. The company further strengthened its portfolio through the 2024 launch of Supor Prime sterilizing-grade filters and the 2025 introduction of the ÄKTA readyflux TFF system 500.

Thermo Fisher Scientific Inc. (US)

Thermo Fisher Scientific offers a comprehensive range of laboratory filtration products through its Life Sciences Solutions and Laboratory Products businesses. Its portfolio includes Nalgene bottle-top filtration systems, syringe filters, membrane filters, vacuum filtration assemblies, and Pierce centrifugal protein concentrators used in sample preparation, sterile filtration, and protein purification. The company's core competencies span laboratory filtration, membrane-based separation, bioprocessing technologies, and integrated research solutions. These products support pharmaceutical research, biotechnology development, clinical laboratories, and academic research applications. In September 2025, Thermo Fisher completed the acquisition of Solventum's Purification & Filtration business for approximately USD 4.0 billion, expanding its membrane and filtration technologies and strengthening its capabilities across upstream and downstream biopharmaceutical processing workflows.

Sartorius AG (Germany)

Sartorius AG is a leading supplier in the laboratory filtration market through its Lab Products & Services and Bioprocess Solutions business segments. The company offers Minisart syringe filters, Sartolab vacuum filtration systems, Vivaspin centrifugal concentrators, Vivaflow ultrafiltration devices, membrane filters, and tangential flow filtration systems. Its core competencies include membrane-based separation, sterile filtration, laboratory sample preparation, and biomolecule concentration and purification. These products serve pharmaceutical and biotechnology companies, academic research institutes, and clinical laboratories. In September 2024, Sartorius launched the Vivaflow SU tangential flow filtration cassette, designed for laboratory-scale ultrafiltration and diafiltration of 100–1,000 mL samples. The company also expanded its membrane manufacturing infrastructure in Göttingen, Germany, strengthening its filtration production capabilities.

Market Ranking

The laboratory filtration market is moderately consolidated, with Merck KGaA (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), and Sartorius AG (Germany) collectively accounting for approximately 60–65% of the global market in 2025. Merck KGaA maintains a leading position through its broad portfolio of membrane filters, syringe filters, ultrafiltration devices, and vacuum filtration systems, supporting laboratory sample preparation, sterile filtration, and purification applications. Danaher Corporation has a strong presence through Cytiva and Pall Life Sciences, offering membrane filters, filter papers, and advanced filtration systems. Thermo Fisher Scientific Inc. strengthens its position through Nalgene filtration products and its expanded membrane technology portfolio. Sartorius AG participates through its Minisart, Vivaspin, Vivaflow, and Sartolab filtration solutions, supporting pharmaceutical, biotechnology, and analytical laboratory applications.

The remaining share of the market, approximately 35–40%, is held by key companies such as Corning Incorporated (US), Agilent Technologies, Inc. (US), Porvair plc (UK), Eaton Corporation plc (Ireland), MACHEREY-NAGEL GmbH & Co. KG (Germany), Avantor, Inc. (US), Alfa Laval Corporate AB (Sweden), Foxx Life Sciences (US), Ahlstrom (Finland), ADVANTEC Group (Japan) and GVS S.p.A. (Italy), among others. Competition is driven by membrane performance, filtration efficiency, chemical compatibility, product quality, application coverage, and technical support. These companies compete through specialized membrane materials, application-specific filtration products, portfolio expansion, product innovation, and broader participation across pharmaceutical research, biotechnology development, clinical testing, and laboratory sample preparation workflows.

Related Reports:

Laboratory Filtration Market by Filters (Membrane [Capsule, Syringe], Depth, Sheet, Disc), Media, Assemblies, Accessories), Material (PES, PVDF, Nylon, PTFE), Technique (Ultrafiltration, Microfiltration, Nanofiltration), End User - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]

Laboratory Filtration Market Size,  Share & Growth Report
Report Code
BT 2761
RI Published ON
November 2026
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
X
GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

SEND ME A FREE SAMPLE
ONLINE CHAT
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved